A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 25
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MIL
Long Form : miltefosine
No. Year Title Co-occurring Abbreviation
2019 Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure. VL
2019 Interactions of miltefosine with erythrocyte membrane proteins compared to those of ionic surfactants. EPR
2018 Ethanolic leaf extract of Coccinia grandis is effective against both drug resistant and drug sensitive clinical isolates of Indian Kala-azar. KA, SSG
2018 Evaluating drug resistance in visceral leishmaniasis: the challenges. AmB, VL
2018 Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions. AmB, AT, GLU, MA, MCL
2018 Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages. IL-10, Lip, TNF-alpha, VL
2018 Potassium iodide and miltefosine inhibit biofilms of Sporothrix schenckii species complex in yeast and filamentous forms. MIC
2018 Resistance of Leishmania (Viannia) Panamensis to Meglumine Antimoniate or Miltefosine Modulates Neutrophil Effector Functions. MA, NET, ROS
2017 Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress. PKDL, VL
10  2017 Miltefosine Resistant Field Isolate From Indian Kala-Azar Patient Shows Similar Phenotype in Experimental Infection. MIL-R, MIL-S
11  2016 Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes. ---
12  2016 In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization. ---
13  2015 Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major. CL, WT
14  2015 In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model. PMM
15  2015 Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum. ---
16  2015 Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum. ---
17  2014 Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum. PMM
18  2014 In vitro inhibitory effect of miltefosine against strains of Histoplasma capsulatum var. capsulatum and Sporothrix spp. MFCs, MIC
19  2013 In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis. ---
20  2013 Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. CI, VL
21  2013 Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death. ---
22  2013 Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani. PKDL, VL
23  2012 Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis. PMM, VL
24  2011 Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. VL
25  1995 Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide. BPS, CPA